Skip to main content

National Prescribing Indicators 2023-2024: Quarterly reports

The National Prescribing Indicators (NPIs) for 2022-2025 include indicators for primary and secondary care, with a focus on the following priority areas:

  • Analgesics (including opioids, tramadol, and gabapentin and pregabalin)
  • Anticoagulants in atrial fibrillation
  • Antimicrobial stewardship (including total antibacterial items and the ‘4C antimicrobials’: co-amoxiclav, cephalosporins, fluoroquinolones and clindamycin)
  • Decarbonisation of inhalers

These four priority areas were supported by additional indicators:

  • Safety
    • Prescribing safety indicators
    • Hypnotics and anxiolytics
    • Yellow Cards
  • Efficiency
    • Best value biological medicines
    • Low value for prescribing

On a quarterly basis, a report is compiled analysing the performance of each health board against the current set of NPIs.

⇩ National Prescribing Indicators 2023–2024: Analysis of Prescribing Data to September 2023 3.6MB (PDF)
⇩ National Prescribing Indicators 2023–2024: Analysis of Prescribing Data to June 2023 3.9MB (PDF)
Follow AWTTC: